The potential reassessment of cannabinoids, particularly at the federal level, is generating considerable anticipation within the industry. A shift away from Schedule I status, often considered as outdated and https://aadampdtq919247.empirewiki.com/9476260/pot_rescheduling_a_growth_catalyst